BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12888568)

  • 1. Oxygen and iron regulation of iron regulatory protein 2.
    Hanson ES; Rawlins ML; Leibold EA
    J Biol Chem; 2003 Oct; 278(41):40337-42. PubMed ID: 12888568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathway for IRP2 degradation involving 2-oxoglutarate-dependent oxygenase(s) does not require the E3 ubiquitin ligase activity of pVHL.
    Wang J; Pantopoulos K
    Biochim Biophys Acta; 2005 Mar; 1743(1-2):79-85. PubMed ID: 15777842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron-mediated degradation of IRP2, an unexpected pathway involving a 2-oxoglutarate-dependent oxygenase activity.
    Wang J; Chen G; Muckenthaler M; Galy B; Hentze MW; Pantopoulos K
    Mol Cell Biol; 2004 Feb; 24(3):954-65. PubMed ID: 14729944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of endogenous heme synthesis and degradation domain cysteines in cellular iron-dependent degradation of IRP2.
    Bourdon E; Kang DK; Ghosh MC; Drake SK; Wey J; Levine RL; Rouault TA
    Blood Cells Mol Dis; 2003; 31(2):247-55. PubMed ID: 12972033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redox control of iron regulatory protein 2 stability.
    Hausmann A; Lee J; Pantopoulos K
    FEBS Lett; 2011 Feb; 585(4):687-92. PubMed ID: 21281640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron-dependent degradation of IRP2 requires its C-terminal region and IRP structural integrity.
    Wang J; Chen G; Lee J; Pantopoulos K
    BMC Mol Biol; 2008 Jan; 9():15. PubMed ID: 18226225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of heme regulatory motif in heme-mediated ubiquitination and degradation of IRP2.
    Ishikawa H; Kato M; Hori H; Ishimori K; Kirisako T; Tokunaga F; Iwai K
    Mol Cell; 2005 Jul; 19(2):171-81. PubMed ID: 16039587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FBXL5 Regulates IRP2 Stability in Iron Homeostasis via an Oxygen-Responsive [2Fe2S] Cluster.
    Wang H; Shi H; Rajan M; Canarie ER; Hong S; Simoneschi D; Pagano M; Bush MF; Stoll S; Leibold EA; Zheng N
    Mol Cell; 2020 Apr; 78(1):31-41.e5. PubMed ID: 32126207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for lysosomes in the turnover of human iron regulatory protein 2.
    Dycke C; Charbonnier P; Pantopoulos K; Moulis JM
    Int J Biochem Cell Biol; 2008; 40(12):2826-32. PubMed ID: 18582596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HOIL-1 is not required for iron-mediated IRP2 degradation in HEK293 cells.
    Zumbrennen KB; Hanson ES; Leibold EA
    Biochim Biophys Acta; 2008 Feb; 1783(2):246-52. PubMed ID: 17822790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the ubiquitin-protein ligase that recognizes oxidized IRP2.
    Yamanaka K; Ishikawa H; Megumi Y; Tokunaga F; Kanie M; Rouault TA; Morishima I; Minato N; Ishimori K; Iwai K
    Nat Cell Biol; 2003 Apr; 5(4):336-40. PubMed ID: 12629548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron regulatory protein 2 turnover through a nonproteasomal pathway.
    Chang AH; Jeong J; Levine RL
    J Biol Chem; 2011 Jul; 286(27):23698-707. PubMed ID: 21558272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of iron homeostasis by an iron-regulated ubiquitin ligase.
    Vashisht AA; Zumbrennen KB; Huang X; Powers DN; Durazo A; Sun D; Bhaskaran N; Persson A; Uhlen M; Sangfelt O; Spruck C; Leibold EA; Wohlschlegel JA
    Science; 2009 Oct; 326(5953):718-21. PubMed ID: 19762596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An E3 ligase possessing an iron-responsive hemerythrin domain is a regulator of iron homeostasis.
    Salahudeen AA; Thompson JW; Ruiz JC; Ma HW; Kinch LN; Li Q; Grishin NV; Bruick RK
    Science; 2009 Oct; 326(5953):722-6. PubMed ID: 19762597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia post-translationally activates iron-regulatory protein 2.
    Hanson ES; Foot LM; Leibold EA
    J Biol Chem; 1999 Feb; 274(8):5047-52. PubMed ID: 9988751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium nitroprusside promotes IRP2 degradation via an increase in intracellular iron and in the absence of S nitrosylation at C178.
    Wang J; Fillebeen C; Chen G; Andriopoulos B; Pantopoulos K
    Mol Cell Biol; 2006 Mar; 26(5):1948-54. PubMed ID: 16479012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of iron regulatory protein regulation on iron homeostasis during hypoxia.
    Schneider BD; Leibold EA
    Blood; 2003 Nov; 102(9):3404-11. PubMed ID: 12855587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide inhibits the degradation of IRP2.
    Wang J; Chen G; Pantopoulos K
    Mol Cell Biol; 2005 Feb; 25(4):1347-53. PubMed ID: 15684386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic characterization and identification of a novel inhibitor of hypoxia-inducible factor prolyl hydroxylase 2 using a time-resolved fluorescence resonance energy transfer-based assay technology.
    Dao JH; Kurzeja RJ; Morachis JM; Veith H; Lewis J; Yu V; Tegley CM; Tagari P
    Anal Biochem; 2009 Jan; 384(2):213-23. PubMed ID: 18952043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and biochemical characterization of iron regulatory proteins 1 and 2 in Saccharomyces cerevisiae.
    Phillips JD; Guo B; Yu Y; Brown FM; Leibold EA
    Biochemistry; 1996 Dec; 35(49):15704-14. PubMed ID: 8961933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.